301281.SZShenzhen
Shandong Keyuan Pharmaceutical Co., Ltd.
¥50.18
ListedApr 4, 2023
SectorHealthcare
IndustryDrug Manufacturers — General
CountryChina
Employees650
State-| CityJinan| AddressKeyuan Street| Phone86 531 8872 9285
Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofenac; chlorzoxazone; esomeprazole sodium; palonosetron hydrochloride; dalafeng; piroxicam; phenylephrine; vildagliptin; parecoxib sodium; ruxolitinib hydrochloride; and lurasidone hydrochloride. The company was founded in 2004 and is headquartered in Jinan, China.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
189.1
?
Div. Rate
¥0.20
?
Div. Yield
0.53%
?
Payout Ratio
93.24%
?
Max Consec. Div. Years
3 years
?
Longest Consec. Div.
2 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.28
?
Div. Growth Rate
0.00%
?
Score
72

Dividend History

Historical dividend payments by ex-dividend date.

May 20, 2025
¥ 0.2000
Apr 30, 2024
¥ 0.3000
May 26, 2023
¥ 0.4000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!